Product Description:
Regorafenib is an oral multi-kinase inhibitor involved in normal cellular functioning and in pathological processes such as oncogenesis, tumor angiogenesis, metastasis, and tumor immunity.It is used in the therapy of metastatic colorectal cancer , gastrointestinal stromal tumor and hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib.
Product Features:
Product Name : Regonix
Generic Name : Regorafenib
Formulation : Tablet
Available Pack Size : 28’s
Available Strengths : 40mg
Categories : Anti-Cancer
Manufacturer : Beacon Pharmaceuticals Ltd.
Reviews
There are no reviews yet.